EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning

Robert J Paproski, Desmond Pink, Deborah L Sosnowski, Catalina Vasquez, John D Lewis iD

Molecular Oncology · 2023-03 · 17 (3) · 407-421

DOI: 10.1002/1878-0261.13362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 29.12.2022. Verfasst von Robert J Paproski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, Prostatic Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alberta Cancer Foundation, Prostate Cancer Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are highly abundant in human biofluids, containing a repertoire of macromolecules and biomarkers representative of the tissue of origin. EVs released by tumours can communicate key signals both locally and to distant sites to promote growth and survival or impact invasive and metastatic progression. Microscale flow cytometry of circulating EVs is an emerging technology that is a promising alternative to biopsy for disease diagnosis. However, biofluid‐derived EVs are highly heterogeneous in size and composition, making their analysis complex. To address this, we developed a machine learning approach combined with EV microscale cytometry using tissue‐ and disease‐specific biomarkers to generate predictive models. We demonstrate the utility of this novel extracellular vesicle machine learning analysis platform (EVMAP) to predict disease from patient samples by developing a blood test to identify high‐grade prostate cancer and validate its performance in a prospective 215 patient cohort. Models generated using the EVMAP approach significantly improved the prediction of high‐risk prostate cancer, highlighting the clinical utility of this diagnostic platform for improved cancer prediction from a blood test.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesProstatic NeoplasmsMaleHumansFlow CytometryProspective StudiesBiomarkers

Stichwörter der Autor:innen

cancer predictiondiagnostic testextracellular vesiclesmachine learningmicroflow cytometryprostate cancer

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Oncology, University of Alberta, Edmonton, AB, Canada.
  • Nanostics Inc., Edmonton, AB, Canada.

ORCID-Profile: John D Lewis

Förderung

  • Alberta Cancer Foundation
  • Prostate Cancer Canada

Zitieren

APA

Paproski, R. J., Pink, D., Sosnowski, D. L., Vasquez, C., & Lewis, J. D. (2023). Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning. Molecular Oncology, 17(3), 407-421. https://doi.org/10.1002/1878-0261.13362

Vancouver

Paproski RJ, Pink D, Sosnowski DL, Vasquez C, Lewis JD. Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning. Molecular Oncology. 2023;17(3):407-421. doi:10.1002/1878-0261.13362

BibTeX
@article{Paproski2023,
  author = {Paproski, Robert J and Pink, Desmond and Sosnowski, Deborah L and Vasquez, Catalina and Lewis, John D},
  title = {Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning},
  journal = {Molecular Oncology},
  year = {2023},
  volume = {17},
  number = {3},
  pages = {407--421},
  doi = {10.1002/1878-0261.13362}
}
Kostenlos starten →